ReviewClinical neurology and neurosurgery2013
Next generation sequencing for neurological diseases: new hope or new hype?
Review in Clinical neurology and neurosurgery, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Navigating triplet repeats sequencing: concepts, methodological challenges and perspective for Huntington's disease.Nucleic acids research · 2025Review
- Next-generation sequencing and bioinformatics in rare movement disorders.Nature reviews. Neurology · 2024Review
- Neurogenomics in Africa: current state, challenges, opportunities, and recommendation.Annals of medicine and surgery (2012) · 2023Article
- Current Status of Next-Generation Sequencing Approaches for Candidate Gene Discovery in Familial Parkinson´s Disease.Frontiers in genetics · 2022Article
- Molecular diagnosis of muscular diseases in outpatient clinics: A Canadian perspective.Neurology. Genetics · 2020Article
- Genetic landscape of autism spectrum disorder in Vietnamese children.Scientific reports · 2020Article
- Practices and views of neurologists regarding the use of whole-genome sequencing in clinical settings: a web-based survey.European journal of human genetics : EJHG · 2017Article
- Detection of genomic rearrangements from targeted resequencing data in Parkinson's disease patients.Movement disorders : official journal of the Movement Disorder Society · 2017Article
- Neurogenomics in Africa: Perspectives, progress, possibilities and priorities.Journal of the neurological sciences · 2016Review
- Targeted Exome Sequencing Outcome Variations of Colorectal Tumors within and across Two Sequencing Platforms.Next generation, sequencing & applications · 2016Article
- Finding FMR1 mosaicism in Fragile X syndrome.Expert review of molecular diagnostics · 2016Article
- Management of Incidental Findings in the Era of Next-generation Sequencing.Current genomics · 2015Article
- Human mitochondrial leucyl tRNA synthetase can suppress non cognate pathogenic mt-tRNA mutations.EMBO molecular medicine · 2014Article
- Genetic Testing in Neurology: What Every Neurologist Must Know.Annals of Indian Academy of NeurologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Over the past year huge advances have been made in our ability to determine the genetic aetiology of many neurological diseases through the utilisation of next generation sequencing platforms. This technology is, on a daily basis, providing new breakthroughs in neurological disease. The aim of this article is to clearly describe the technological platforms, methods of data analysis, established breakthroughs, and potential future clinical and research applications of this innovative and exciting technique which has relevance to all those working within clinical neuroscience.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.